Showing results (11-20 of 903) with videos related to

Sort By:
Pageof 91
The Lancet. Psychiatry|November 4, 2021
Associations between plasma fatty acid concentrations and schizophrenia: a two-sample Mendelian randomisation studyHannah J Jones, Maria Carolina Borges, Rebecca Carnegie, et al.
The Lancet. Psychiatry|October 16, 2022
Maintenance ketamine treatment for depression: a systematic review of efficacy, safety, and tolerabilitySanne Y Smith-Apeldoorn, Jolien Ke Veraart, Jan Spijker, et al.
The Lancet. Psychiatry|September 12, 2015
Intensive case management for high-risk patients with first-episode psychosis: service model and outcomesWarrick J Brewer, Timothy J Lambert, Katrina Witt, et al.
The Lancet. Psychiatry|September 12, 2015
Clinical effectiveness of a staff training intervention in mental health inpatient rehabilitation units designed to increase patients' engagement in activities (the Rehabilitation Effectiveness for Activities for Life [REAL] study): single-blind, cluster-randomised controlled trialHelen Killaspy, Louise Marston, Nicholas Green, et al.
The Lancet. Psychiatry|September 12, 2015
Global mental health and neuroscience: potential synergiesDan J Stein, Yanling He, Anthony Phillips, et al.
The Lancet. Psychiatry|September 12, 2015
Proportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: a case-control studyMarta Di Forti, Arianna Marconi, Elena Carra, et al.
The Lancet. Psychiatry|September 12, 2015
Targeting the biased brain: non-invasive brain stimulation to ameliorate cognitive controlChristian Plewnia, Philipp A Schroeder, Larissa Wolkenstein
The Lancet. Psychiatry|September 12, 2015
The epidemiology of diabetes in psychotic disordersMartha Ward, Benjamin Druss
The Lancet. Psychiatry|September 12, 2015
Clinical management of comorbid diabetes and psychotic disordersLydia A Chwastiak, Oliver Freudenreich, Cenk Tek, et al.
The Lancet. Psychiatry|September 12, 2015
Monitoring white blood cell count in adult patients with schizophrenia who are taking clozapine: a cost-effectiveness analysisFrançois R Girardin, Antoine Poncet, Marc Blondon, et al.
Pageof 91